QT Imaging (QTI) Competitors

$6.79 +0.26 (+3.98%)

Closing price 04:00 PM Eastern

Extended Trading

$6.78 -0.01 (-0.15%)

As of 05:27 PM Eastern

QTI vs. RXST, TLSI, SI, PROF, and CARL

Should you be buying QT Imaging stock or one of its competitors? The main competitors of QT Imaging include RxSight (RXST), TriSalus Life Sciences (TLSI), Shoulder Innovations (SI), Profound Medical (PROF), and Carlsmed (CARL). These companies are all part of the "medical equipment" industry.

How does QT Imaging compare to RxSight?

RxSight (NASDAQ:RXST) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment.

: QT Imaging has lower revenue, but higher earnings than RxSight. RxSight is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
RxSight $134.48M 2.24 -$38.94M -$0.95 N/A
QT Imaging $18.93M 4.32 -$21.08M -$2.19 N/A
: RxSight has a net margin of -28.96% compared to QT Imaging's net margin of -111.40%. QT Imaging's return on equity of 0.00% beat RxSight's return on equity.
Company Net Margins Return on Equity Return on Assets
RxSight -28.96% -14.05% -12.54%
QT Imaging -111.40% N/A -115.44%
: 78.8% of RxSight shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 9.6% of RxSight shares are held by insiders. Comparatively, 28.8% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
: RxSight has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500.
: In the previous week, RxSight had 2 more articles in the media than QT Imaging. MarketBeat recorded 3 mentions for RxSight and 1 mentions for QT Imaging. RxSight's average media sentiment score of 0.00 equaled QT Imaging'saverage media sentiment score.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RxSight
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
QT Imaging
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: RxSight currently has a consensus price target of $9.78, suggesting a potential upside of 34.68%. Given RxSight's higher probable upside, analysts plainly believe RxSight is more favorable than QT Imaging.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RxSight
3 Sell rating(s)
10 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
1.93
QT Imaging
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RxSight	$134.48M	2.24	-$38.94M	-$0.95	N/A
QT Imaging	$18.93M	4.32	-$21.08M	-$2.19	N/A

Company	Net Margins	Return on Equity	Return on Assets
RxSight	-28.96%	-14.05%	-12.54%
QT Imaging	-111.40%	N/A	-115.44%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RxSight	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
QT Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RxSight	3 Sell rating(s)	10 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.93
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

RxSight beats QT Imaging on 9 of the 15 factors compared between the two stocks.

How does QT Imaging compare to TriSalus Life Sciences?

TriSalus Life Sciences (NASDAQ:TLSI) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

: TriSalus Life Sciences currently has a consensus price target of $7.00, suggesting a potential upside of 51.84%. Given TriSalus Life Sciences' higher probable upside, equities analysts plainly believe TriSalus Life Sciences is more favorable than QT Imaging.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriSalus Life Sciences
1 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
QT Imaging
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: TriSalus Life Sciences has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500.
: QT Imaging has lower revenue, but higher earnings than TriSalus Life Sciences. QT Imaging is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
TriSalus Life Sciences $45.15M 6.26 -$39.23M -$1.83 N/A
QT Imaging $18.93M 4.32 -$21.08M -$2.19 N/A
: TriSalus Life Sciences has a net margin of -86.88% compared to QT Imaging's net margin of -111.40%.
Company Net Margins Return on Equity Return on Assets
TriSalus Life Sciences -86.88% N/A -94.43%
QT Imaging -111.40% N/A -115.44%
: In the previous week, TriSalus Life Sciences had 2 more articles in the media than QT Imaging. MarketBeat recorded 3 mentions for TriSalus Life Sciences and 1 mentions for QT Imaging. TriSalus Life Sciences' average media sentiment score of 0.00 equaled QT Imaging'saverage media sentiment score.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TriSalus Life Sciences
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
QT Imaging
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: 2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 16.3% of TriSalus Life Sciences shares are held by company insiders. Comparatively, 28.8% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TriSalus Life Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TriSalus Life Sciences	$45.15M	6.26	-$39.23M	-$1.83	N/A
QT Imaging	$18.93M	4.32	-$21.08M	-$2.19	N/A

Company	Net Margins	Return on Equity	Return on Assets
TriSalus Life Sciences	-86.88%	N/A	-94.43%
QT Imaging	-111.40%	N/A	-115.44%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TriSalus Life Sciences	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
QT Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

TriSalus Life Sciences beats QT Imaging on 9 of the 12 factors compared between the two stocks.

How does QT Imaging compare to Shoulder Innovations?

QT Imaging (NASDAQ:QTI) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, media sentiment, dividends, profitability and risk.

: Shoulder Innovations has a net margin of -85.29% compared to QT Imaging's net margin of -111.40%. QT Imaging's return on equity of 0.00% beat Shoulder Innovations' return on equity.
Company Net Margins Return on Equity Return on Assets
QT Imaging -111.40% N/A -115.44%
Shoulder Innovations -85.29% -37.68% -18.63%
: In the previous week, Shoulder Innovations had 1 more articles in the media than QT Imaging. MarketBeat recorded 2 mentions for Shoulder Innovations and 1 mentions for QT Imaging. Shoulder Innovations' average media sentiment score of 1.65 beat QT Imaging's score of 0.00 indicating that Shoulder Innovations is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QT Imaging
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Shoulder Innovations
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
: 24.2% of QT Imaging shares are held by institutional investors. 28.8% of QT Imaging shares are held by company insiders. Comparatively, 1.7% of Shoulder Innovations shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
: Shoulder Innovations has a consensus price target of $20.80, suggesting a potential upside of 60.63%. Given Shoulder Innovations' stronger consensus rating and higher possible upside, analysts clearly believe Shoulder Innovations is more favorable than QT Imaging.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
1 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
Shoulder Innovations
1 Sell rating(s)

1 Hold rating(s)

5 Buy rating(s)

0 Strong Buy rating(s)
2.57
: QT Imaging has higher earnings, but lower revenue than Shoulder Innovations. QT Imaging is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
QT Imaging $18.93M 4.32 -$21.08M -$2.19 N/A
Shoulder Innovations $47.32M 5.67 -$40.36M -$218.68 N/A

Company	Net Margins	Return on Equity	Return on Assets
QT Imaging	-111.40%	N/A	-115.44%
Shoulder Innovations	-85.29%	-37.68%	-18.63%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QT Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Shoulder Innovations	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$18.93M	4.32	-$21.08M	-$2.19	N/A
Shoulder Innovations	$47.32M	5.67	-$40.36M	-$218.68	N/A

Summary

Shoulder Innovations beats QT Imaging on 10 of the 15 factors compared between the two stocks.

How does QT Imaging compare to Profound Medical?

Profound Medical (NASDAQ:PROF) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

: QT Imaging has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Profound Medical $16.10M 16.41 -$42.57M -$1.41 N/A
QT Imaging $18.93M 4.32 -$21.08M -$2.19 N/A
: Profound Medical presently has a consensus target price of $12.00, suggesting a potential upside of 65.06%. Given Profound Medical's higher probable upside, research analysts clearly believe Profound Medical is more favorable than QT Imaging.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Profound Medical
1 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
QT Imaging
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: 47.9% of Profound Medical shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 1.5% of Profound Medical shares are held by insiders. Comparatively, 28.8% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
: Profound Medical has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500.
: In the previous week, Profound Medical and Profound Medical both had 1 articles in the media. Profound Medical's average media sentiment score of 0.00 equaled QT Imaging'saverage media sentiment score.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Profound Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
QT Imaging
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: QT Imaging has a net margin of -111.40% compared to Profound Medical's net margin of -264.45%. QT Imaging's return on equity of 0.00% beat Profound Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
Profound Medical -264.45% -90.28% -73.94%
QT Imaging -111.40% N/A -115.44%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$16.10M	16.41	-$42.57M	-$1.41	N/A
QT Imaging	$18.93M	4.32	-$21.08M	-$2.19	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
QT Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-264.45%	-90.28%	-73.94%
QT Imaging	-111.40%	N/A	-115.44%

Summary

Profound Medical and QT Imaging tied by winning 6 of the 12 factors compared between the two stocks.

How does QT Imaging compare to Carlsmed?

Carlsmed (NASDAQ:CARL) and QT Imaging (NASDAQ:QTI) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

: Carlsmed has a net margin of -58.67% compared to QT Imaging's net margin of -111.40%. QT Imaging's return on equity of 0.00% beat Carlsmed's return on equity.
Company Net Margins Return on Equity Return on Assets
Carlsmed -58.67% -72.60% -27.93%
QT Imaging -111.40% N/A -115.44%
: 24.2% of QT Imaging shares are held by institutional investors. 28.8% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
: QT Imaging has lower revenue, but higher earnings than Carlsmed. QT Imaging is trading at a lower price-to-earnings ratio than Carlsmed, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Carlsmed $50.51M 4.81 -$29.63M -$3.66 N/A
QT Imaging $18.93M 4.32 -$21.08M -$2.19 N/A
: Carlsmed currently has a consensus target price of $19.67, suggesting a potential upside of 120.48%. Given Carlsmed's stronger consensus rating and higher possible upside, analysts clearly believe Carlsmed is more favorable than QT Imaging.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Carlsmed
1 Sell rating(s)
1 Hold rating(s)

3 Buy rating(s)

0 Strong Buy rating(s)
2.40
QT Imaging
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: In the previous week, Carlsmed had 2 more articles in the media than QT Imaging. MarketBeat recorded 3 mentions for Carlsmed and 1 mentions for QT Imaging. Carlsmed's average media sentiment score of 0.90 beat QT Imaging's score of 0.00 indicating that Carlsmed is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Carlsmed
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
QT Imaging
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-58.67%	-72.60%	-27.93%
QT Imaging	-111.40%	N/A	-115.44%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$50.51M	4.81	-$29.63M	-$3.66	N/A
QT Imaging	$18.93M	4.32	-$21.08M	-$2.19	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Carlsmed	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
QT Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Carlsmed beats QT Imaging on 10 of the 15 factors compared between the two stocks.

Get QT Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QTI vs. The Competition

Export

Metric	QT Imaging	Electromedical equipment Industry	Medical Sector	NASDAQ Exchange
Market Cap	$81.77M	$64.87M	$6.25B	$11.87B
Dividend Yield	N/A	N/A	2.73%	5.21%
P/E Ratio	-3.10	5.74	29.04	28.47
Price / Sales	4.32	207.65	476.61	60.92
Price / Cash	N/A	41.36	27.62	36.52
Price / Book	12.57	6.04	9.67	6.67
Net Income	-$21.08M	-$5.50M	$3.55B	$332.53M
7 Day Performance	4.14%	24.54%	1.70%	2.01%
1 Month Performance	3.66%	23.99%	5.62%	9.19%
1 Year Performance	759.49%	272.18%	34.41%	39.59%

QT Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QTI QT Imaging	0.2312 of 5 stars	$6.79 +4.0%	N/A	N/A	$81.77M	$18.93M	N/A	N/A	News Coverage Upcoming Earnings
RXST RxSight	1.5643 of 5 stars	$7.01 +2.9%	$9.78 +39.5%	N/A	$289.30M	$134.48M	N/A	220	Upcoming Earnings
TLSI TriSalus Life Sciences	1.6192 of 5 stars	$4.38 +2.8%	$7.00 +59.8%	N/A	$268.23M	$45.15M	N/A	106	Upcoming Earnings
SI Shoulder Innovations	3.1727 of 5 stars	$12.75 +3.9%	$20.80 +63.1%	N/A	$263.32M	$47.32M	N/A	61	Positive News
PROF Profound Medical	1.1521 of 5 stars	$6.68 +2.0%	$12.00 +79.5%	N/A	$242.88M	$16.10M	N/A	150	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QTI) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

QT Imaging (QTI) Competitors

QTI vs. RXST, TLSI, SI, PROF, and CARL

How does QT Imaging compare to RxSight?

Summary

How does QT Imaging compare to TriSalus Life Sciences?

Summary

How does QT Imaging compare to Shoulder Innovations?

Summary

How does QT Imaging compare to Profound Medical?

Summary

How does QT Imaging compare to Carlsmed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTI vs. The Competition

QT Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

QT Imaging (QTI) Competitors

QTI vs. RXST, TLSI, SI, PROF, and CARL

How does QT Imaging compare to RxSight?

Summary

How does QT Imaging compare to TriSalus Life Sciences?

Summary

How does QT Imaging compare to Shoulder Innovations?

Summary

How does QT Imaging compare to Profound Medical?

Summary

How does QT Imaging compare to Carlsmed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTI vs. The Competition

QT Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools